393 related articles for article (PubMed ID: 32515157)
41. Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I-III unilateral breast cancer in the USA, 1998-2016.
Yang Y; Pan L; Shao Z
Breast Cancer Res Treat; 2021 Dec; 190(3):503-515. PubMed ID: 34554371
[TBL] [Abstract][Full Text] [Related]
42. Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status.
Hwang ES; Lichtensztajn DY; Gomez SL; Fowble B; Clarke CA
Cancer; 2013 Apr; 119(7):1402-11. PubMed ID: 23359049
[TBL] [Abstract][Full Text] [Related]
43. [Long-term recurrence rate and survival in different aged patients with breast cancer undergoing breast conserving therapy].
Wang LZ; Li JF; Wang TF; Xie YT; Fan ZQ; He YJ; Ouyang T
Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):127-133. PubMed ID: 33378805
[No Abstract] [Full Text] [Related]
44. Effect of postoperative radiotherapy in women with localized pure mucinous breast cancer after lumpectomy: a population-based study.
Mo Q; Wang Y; Shan J; Wang X
Radiat Oncol; 2022 Jul; 17(1):119. PubMed ID: 35799256
[TBL] [Abstract][Full Text] [Related]
45. Is Breast-Conserving Therapy Appropriate for Male Breast Cancer Patients? A National Cancer Database Analysis.
Bateni SB; Davidson AJ; Arora M; Daly ME; Stewart SL; Bold RJ; Canter RJ; Sauder CAM
Ann Surg Oncol; 2019 Jul; 26(7):2144-2153. PubMed ID: 30761438
[TBL] [Abstract][Full Text] [Related]
46. Clinicopathological characteristics and treatment outcomes of occult breast cancer: a population-based study.
Zhao Z; Zhang T; Yao Y; Lu X
BMC Surg; 2022 Apr; 22(1):143. PubMed ID: 35430796
[TBL] [Abstract][Full Text] [Related]
47. Breast-conserving therapy for breast cancer with BRCA mutations: a meta-analysis.
Wang C; Lin Y; Zhu H; Zhou Y; Mao F; Huang X; Zhou X; Cao X; Sun Q
Breast Cancer; 2022 Mar; 29(2):314-323. PubMed ID: 34766244
[TBL] [Abstract][Full Text] [Related]
48. Survival is Better After Breast Conserving Therapy than Mastectomy for Early Stage Breast Cancer: A Registry-Based Follow-up Study of Norwegian Women Primary Operated Between 1998 and 2008.
Hartmann-Johnsen OJ; Kåresen R; Schlichting E; Nygård JF
Ann Surg Oncol; 2015 Nov; 22(12):3836-45. PubMed ID: 25743325
[TBL] [Abstract][Full Text] [Related]
49. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
[No Abstract] [Full Text] [Related]
50. Should women younger than 40 years of age with invasive breast cancer have a mastectomy? 15-year outcomes in a population-based cohort.
Cao JQ; Truong PT; Olivotto IA; Olson R; Coulombe G; Keyes M; Weir L; Gelmon K; Bernstein V; Woods R; Speers C; Tyldesley S
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):509-17. PubMed ID: 25194665
[TBL] [Abstract][Full Text] [Related]
51. Omission of adjuvant radiotherapy following breast-conserving surgery for elderly women with early-stage pure mucinous breast carcinoma.
Wu SG; Li FY; Wang J; Lian CL; Zhou J; He ZY
Radiat Oncol; 2019 Nov; 14(1):190. PubMed ID: 31685005
[TBL] [Abstract][Full Text] [Related]
52. Diminished survival in patients with inner versus outer quadrant breast cancers.
Gaffney DK; Tsodikov A; Wiggins CL
J Clin Oncol; 2003 Feb; 21(3):467-72. PubMed ID: 12560437
[TBL] [Abstract][Full Text] [Related]
53. Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer.
Agarwal S; Pappas L; Neumayer L; Kokeny K; Agarwal J
JAMA Surg; 2014 Mar; 149(3):267-74. PubMed ID: 24429935
[TBL] [Abstract][Full Text] [Related]
54. Breast-conserving therapy is safe both within
Huang X; Cai XY; Liu JQ; Hao WW; Zhou YD; Wang X; Xu Y; Chen C; Lin Y; Wang CJ; Song Y; Sun Q
Gland Surg; 2020 Jun; 9(3):775-787. PubMed ID: 32775268
[TBL] [Abstract][Full Text] [Related]
55. Survival and disease-free benefits with mastectomy versus breast conservation therapy for early breast cancer: a meta-analysis.
Chen Y; Jiang L; Gao B; Cheng ZY; Jin J; Yang KH
Breast Cancer Res Treat; 2016 Jun; 157(3):517-25. PubMed ID: 27246814
[TBL] [Abstract][Full Text] [Related]
56. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial.
Litière S; Werutsky G; Fentiman IS; Rutgers E; Christiaens MR; Van Limbergen E; Baaijens MH; Bogaerts J; Bartelink H
Lancet Oncol; 2012 Apr; 13(4):412-9. PubMed ID: 22373563
[TBL] [Abstract][Full Text] [Related]
57. Long-term overall survival of patients who undergo breast-conserving therapy or mastectomy for early operable HER2-Positive breast cancer after preoperative systemic therapy: an observational cohort study.
He X; Ji J; Qdaisat A; Esteva FJ; Yeung SJ
Lancet Reg Health Am; 2024 Apr; 32():100712. PubMed ID: 38495316
[TBL] [Abstract][Full Text] [Related]
58. Adjuvant chemotherapy could benefit early-stage ER/PR positive mucinous breast cancer: A SEER-based analysis.
Gao HF; Li WP; Zhu T; Yang CQ; Yang M; Zhang LL; Ji F; Cheng MY; Li JQ; Wang K
Breast; 2020 Dec; 54():79-87. PubMed ID: 32947149
[TBL] [Abstract][Full Text] [Related]
59. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
[TBL] [Abstract][Full Text] [Related]
60. Is Breast Conserving Therapy a Safe Modality for Early-Stage Male Breast Cancer?
Zaenger D; Rabatic BM; Dasher B; Mourad WF
Clin Breast Cancer; 2016 Apr; 16(2):101-4. PubMed ID: 26718092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
